{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:40:57Z","timestamp":1787431257358,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s13760-020-01505-0","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T05:02:33Z","timestamp":1602133353000},"page":"1755-1760","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rare slow channel congenital myasthenic syndromes without repetitive compound muscle action potential and dramatic response to low dose fluoxetine"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6426-676X","authenticated-orcid":false,"given":"Hacer","family":"Durmus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Sticht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Ceylaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Hashemolhosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feza","family":"Deymeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"issue":"5","key":"1505_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S1474-4422(15)00010-1","volume":"14","author":"AG Engel","year":"2015","unstructured":"Engel AG, Shen XM, Selcen D, Sine SM (2015) Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol 14(5):461. https:\/\/doi.org\/10.1016\/S1474-4422(15)00010-1","journal-title":"Lancet Neurol"},{"issue":"10","key":"1505_CR2","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1002\/humu.22130","volume":"33","author":"A Abicht","year":"2012","unstructured":"Abicht A, Dusl M, Gallenmuller C, Guergueltcheva V, Schara U, Della Marina A, Wibbeler E, Almaras S, Mihaylova V, von der Hagen M, Huebner A, Chaouch A, Muller JS, Lochmuller H (2012) Congenital myasthenic syndromes: achievements and limitations of phenotype-guided gene-after-gene sequencing in diagnostic practice: a study of 680 patients. Hum Mutat 33(10):1474\u20131484. https:\/\/doi.org\/10.1002\/humu.22130","journal-title":"Hum Mutat"},{"issue":"5","key":"1505_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/WCO.0000000000000370","volume":"29","author":"D Beeson","year":"2016","unstructured":"Beeson D (2016) Congenital myasthenic syndromes: recent advances. Curr Opin Neurol 29(5):565\u2013571. https:\/\/doi.org\/10.1097\/WCO.0000000000000370","journal-title":"Curr Opin Neurol"},{"issue":"9","key":"1505_CR4","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1093\/hmg\/5.9.1217","volume":"5","author":"AG Engel","year":"1996","unstructured":"Engel AG, Ohno K, Milone M, Wang HL, Nakano S, Bouzat C, Pruitt JN, Hutchinson DO, Brengman JM, Bren N, Sieb JP, Sine SM (1996) New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet 5(9):1217\u20131227. https:\/\/doi.org\/10.1093\/hmg\/5.9.1217","journal-title":"Hum Mol Genet"},{"issue":"5","key":"1505_CR5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/hmg\/6.5.767","volume":"6","author":"R Croxen","year":"1997","unstructured":"Croxen R, Newland C, Beeson D, Oosterhuis H, Chauplannaz G, Vincent A, Newsom-Davis J (1997) Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome. Hum Mol Genet 6(5):767\u2013774. https:\/\/doi.org\/10.1093\/hmg\/6.5.767","journal-title":"Hum Mol Genet"},{"issue":"15","key":"1505_CR6","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.1523\/JNEUROSCI.17-15-05651.1997","volume":"17","author":"M Milone","year":"1997","unstructured":"Milone M, Wang HL, Ohno K, Fukudome T, Pruitt JN, Bren N, Sine SM, Engel AG (1997) Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit. J Neurosci 17(15):5651\u20135665","journal-title":"J Neurosci"},{"issue":"10","key":"1505_CR7","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/humu.23043","volume":"37","author":"XM Shen","year":"2016","unstructured":"Shen XM, Okuno T, Milone M, Otsuka K, Takahashi K, Komaki H, Giles E, Ohno K, Engel AG (2016) Mutations causing slow-channel myasthenia reveal that a valine ring in the channel pore of muscle AChR is optimized for stabilizing channel gating. Hum Mutat 37(10):1051\u20131059. https:\/\/doi.org\/10.1002\/humu.23043","journal-title":"Hum Mutat"},{"issue":"21","key":"1505_CR8","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.4103\/0366-6999.192780","volume":"129","author":"JZ Tan","year":"2016","unstructured":"Tan JZ, Man Y, Xiao F (2016) A missense mutation in epsilon-subunit of acetylcholine receptor causing autosomal dominant slow-channel congenital myasthenic syndrome in a chinese family. Chin Med J (Engl) 129(21):2596\u20132602. https:\/\/doi.org\/10.4103\/0366-6999.192780","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"1505_CR9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s10072-018-3645-2","volume":"40","author":"C Angelini","year":"2019","unstructured":"Angelini C, Lispi L, Salvoro C, Mostacciuolo ML, Vazza G (2019) Clinical and genetic characterization of an Italian family with slow-channel syndrome. Neurol Sci 40(3):503\u2013507. https:\/\/doi.org\/10.1007\/s10072-018-3645-2","journal-title":"Neurol Sci"},{"issue":"1","key":"1505_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/ana.10077[pii]","volume":"51","author":"CM Gomez","year":"2002","unstructured":"Gomez CM, Maselli RA, Vohra BP, Navedo M, Stiles JR, Charnet P, Schott K, Rojas L, Keesey J, Verity A, Wollmann RW, Lasalde-Dominicci J (2002) Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanisms. Ann Neurol 51(1):102\u2013112. https:\/\/doi.org\/10.1002\/ana.10077[pii]","journal-title":"Ann Neurol"},{"issue":"3","key":"1505_CR11","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s00415-011-6204-9","volume":"259","author":"A Chaouch","year":"2012","unstructured":"Chaouch A, Muller JS, Guergueltcheva V, Dusl M, Schara U, Rakocevic-Stojanovic V, Lindberg C, Scola RH, Werneck LC, Colomer J, Nascimento A, Vilchez JJ, Muelas N, Argov Z, Abicht A, Lochmuller H (2012) A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome. J Neurol 259(3):474\u2013481. https:\/\/doi.org\/10.1007\/s00415-011-6204-9","journal-title":"J Neurol"},{"issue":"4","key":"1505_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.nmd.2017.11.013","volume":"28","author":"H Durmus","year":"2018","unstructured":"Durmus H, Shen XM, Serdaroglu-Oflazer P, Kara B, Parman-Gulsen Y, Ozdemir C, Brengman J, Deymeer F, Engel AG (2018) Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up. Neuromuscul Disord 28(4):315\u2013322. https:\/\/doi.org\/10.1016\/j.nmd.2017.11.013S0960-8966(17)31232-4 [pii]","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"1505_CR13","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/ana.410430411","volume":"43","author":"CM Harper","year":"1998","unstructured":"Harper CM, Engel AG (1998) Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome. Ann Neurol 43(4):480\u2013484. https:\/\/doi.org\/10.1002\/ana.410430411","journal-title":"Ann Neurol"},{"issue":"10","key":"1505_CR14","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1212\/01.WNL.0000061483.11417.1B","volume":"60","author":"CM Harper","year":"2003","unstructured":"Harper CM, Fukodome T, Engel AG (2003) Treatment of slow-channel congenital myasthenic syndrome with fluoxetine. Neurology 60(10):1710\u20131713","journal-title":"Neurology"},{"issue":"4","key":"1505_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jmb.2004.12.031","volume":"346","author":"N Unwin","year":"2005","unstructured":"Unwin N (2005) Refined structure of the nicotinic acetylcholine receptor at 4A resolution. J Mol Biol 346(4):967\u2013989. https:\/\/doi.org\/10.1016\/j.jmb.2004.12.031","journal-title":"J Mol Biol"},{"issue":"5","key":"1505_CR16","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jmb.2012.07.010","volume":"422","author":"N Unwin","year":"2012","unstructured":"Unwin N, Fujiyoshi Y (2012) Gating movement of acetylcholine receptor caught by plunge-freezing. J Mol Biol 422(5):617\u2013634. https:\/\/doi.org\/10.1016\/j.jmb.2012.07.010S0022-2836(12)00577-3 [pii]","journal-title":"J Mol Biol"},{"issue":"3","key":"1505_CR17","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.coph.2004.12.007","volume":"5","author":"AG Engel","year":"2005","unstructured":"Engel AG, Sine SM (2005) Current understanding of congenital myasthenic syndromes. Curr Opin Pharmacol 5(3):308\u2013321. https:\/\/doi.org\/10.1016\/j.coph.2004.12.007","journal-title":"Curr Opin Pharmacol"},{"issue":"9","key":"1505_CR18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S0968-0004(00)89080-5","volume":"20","author":"RA Sayle","year":"1995","unstructured":"Sayle RA, Milner-White EJ (1995) RASMOL: biomolecular graphics for all. Trends Biochem Sci 20(9):374","journal-title":"Trends Biochem Sci"},{"issue":"10","key":"1505_CR19","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1002\/acn3.50902","volume":"6","author":"XM Shen","year":"2019","unstructured":"Shen XM, Milone M, Wang HL, Banwell B, Selcen D, Sine SM, Engel AG (2019) Slow-channel myasthenia due to novel mutation in M2 domain of AChR delta subunit. Ann Clin Transl Neurol 6(10):2066\u20132078. https:\/\/doi.org\/10.1002\/acn3.50902","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"1505_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.nmd.2006.02.009","volume":"16","author":"J Colomer","year":"2006","unstructured":"Colomer J, Muller JS, Vernet A, Nascimento A, Pons M, Gonzalez V, Abicht A, Lochmuller H (2006) Long-term improvement of slow-channel congenital myasthenic syndrome with fluoxetine. Neuromuscul Disord 16(5):329\u2013333. https:\/\/doi.org\/10.1016\/j.nmd.2006.02.009S0960-8966(06)00073-3 [pii]","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"1505_CR21","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1469-8749.2008.02038.x","volume":"50","author":"M Pitt","year":"2008","unstructured":"Pitt M (2008) Neurophysiological strategies for the diagnosis of disorders of the neuromuscular junction in children. Dev Med Child Neurol 50(5):328\u2013333. https:\/\/doi.org\/10.1111\/j.1469-8749.2008.02038.x","journal-title":"Dev Med Child Neurol"},{"issue":"Pt 3","key":"1505_CR22","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/brain\/awm325","volume":"131","author":"V Mihaylova","year":"2008","unstructured":"Mihaylova V, Muller JS, Vilchez JJ, Salih MA, Kabiraj MM, D'Amico A, Bertini E, Wolfle J, Schreiner F, Kurlemann G, Rasic VM, Siskova D, Colomer J, Herczegfalvi A, Fabriciova K, Weschke B, Scola R, Hoellen F, Schara U, Abicht A, Lochmuller H (2008) Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes. Brain 131(Pt 3):747\u2013759. https:\/\/doi.org\/10.1093\/brain\/awm325","journal-title":"Brain"},{"issue":"2B","key":"1505_CR23","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1590\/S0004-282X2009000300024","volume":"67","author":"PJ Lorenzoni","year":"2009","unstructured":"Lorenzoni PJ, Scola RH, Gervini BL, Kay CS, Werneck LC (2009) Electrophysiological study in synaptic congenital myasthenic syndrome: end-plate acetylcholinesterase deficiency. Arq Neuropsiquiatr 67(2B):502\u2013504 S0004-282X2009000300024 [pii]","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"1505_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1172\/JCI12935","volume":"108","author":"S Brownlow","year":"2001","unstructured":"Brownlow S, Webster R, Croxen R, Brydson M, Neville B, Lin JP, Vincent A, Newsom-Davis J, Beeson D (2001) Acetylcholine receptor delta subunit mutations underlie a fast-channel myasthenic syndrome and arthrogryposis multiplex congenita. J Clin Invest 108(1):125\u2013130. https:\/\/doi.org\/10.1172\/JCI12935","journal-title":"J Clin Invest"},{"issue":"12","key":"1505_CR25","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1212\/01.WNL.0000042422.87384.2F","volume":"59","author":"XM Shen","year":"2002","unstructured":"Shen XM, Ohno K, Fukudome T, Tsujino A, Brengman JM, De Vivo DC, Packer RJ, Engel AG (2002) Congenital myasthenic syndrome caused by low-expressor fast-channel AChR delta subunit mutation. Neurology 59(12):1881\u20131888","journal-title":"Neurology"},{"issue":"5","key":"1505_CR26","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1172\/JCI34527","volume":"118","author":"XM Shen","year":"2008","unstructured":"Shen XM, Fukuda T, Ohno K, Sine SM, Engel AG (2008) Congenital myasthenia-related AChR delta subunit mutation interferes with intersubunit communication essential for channel gating. J Clin Invest 118(5):1867\u20131876. https:\/\/doi.org\/10.1172\/JCI34527","journal-title":"J Clin Invest"},{"issue":"Pt 10","key":"1505_CR27","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1093\/brain\/awl188","volume":"129","author":"JS Muller","year":"2006","unstructured":"Muller JS, Baumeister SK, Schara U, Cossins J, Krause S, von der Hagen M, Huebner A, Webster R, Beeson D, Lochmuller H, Abicht A (2006) CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn. Brain 129(Pt 10):2784\u20132793. https:\/\/doi.org\/10.1093\/brain\/awl188","journal-title":"Brain"},{"issue":"6943","key":"1505_CR28","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature01748","volume":"423","author":"A Miyazawa","year":"2003","unstructured":"Miyazawa A, Fujiyoshi Y, Unwin N (2003) Structure and gating mechanism of the acetylcholine receptor pore. Nature 423(6943):949\u2013955. https:\/\/doi.org\/10.1038\/nature01748","journal-title":"Nature"},{"issue":"Pt 4","key":"1505_CR29","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/brain\/aws016","volume":"135","author":"R Webster","year":"2012","unstructured":"Webster R, Maxwell S, Spearman H, Tai K, Beckstein O, Sansom M, Beeson D (2012) A novel congenital myasthenic syndrome due to decreased acetylcholine receptor ion-channel conductance. Brain 135(Pt 4):1070\u20131080. https:\/\/doi.org\/10.1093\/brain\/aws016","journal-title":"Brain"},{"issue":"2","key":"1505_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1088\/1478-3975\/3\/2\/007","volume":"3","author":"O Beckstein","year":"2006","unstructured":"Beckstein O, Sansom MS (2006) A hydrophobic gate in an ion channel: the closed state of the nicotinic acetylcholine receptor. Phys Biol 3(2):147\u2013159. https:\/\/doi.org\/10.1088\/1478-3975\/3\/2\/007S1478-3975(06)18065-6 [pii]","journal-title":"Phys Biol"},{"issue":"6509","key":"1505_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/373037a0","volume":"373","author":"N Unwin","year":"1995","unstructured":"Unwin N (1995) Acetylcholine receptor channel imaged in the open state. Nature 373(6509):37\u201343. https:\/\/doi.org\/10.1038\/373037a0","journal-title":"Nature"},{"issue":"6540","key":"1505_CR32","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/376514a0","volume":"376","author":"C Labarca","year":"1995","unstructured":"Labarca C, Nowak MW, Zhang H, Tang L, Deshpande P, Lester HA (1995) Channel gating governed symmetrically by conserved leucine residues in the M2 domain of nicotinic receptors. Nature 376(6540):514\u2013516. https:\/\/doi.org\/10.1038\/376514a0","journal-title":"Nature"},{"issue":"5","key":"1505_CR33","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1212\/WNL.45.5.982","volume":"45","author":"CM Gomez","year":"1995","unstructured":"Gomez CM, Gammack JT (1995) A leucine-to-phenylalanine substitution in the acetylcholine receptor ion channel in a family with the slow-channel syndrome. Neurology 45(5):982\u2013985","journal-title":"Neurology"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01505-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-020-01505-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01505-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T16:36:19Z","timestamp":1636734979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-020-01505-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1505"],"URL":"https:\/\/doi.org\/10.1007\/s13760-020-01505-0","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,8]]},"assertion":[{"value":"7 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors has any conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}